RT @IPNA_PedNeph: One click to read about Eculizumab treatment in our free article of this month: https://t.co/2OS1njOMdY @Ped_Neph https:/…
RT @IPNA_PedNeph: One click to read about Eculizumab treatment in our free article of this month: https://t.co/2OS1njOMdY @Ped_Neph https:/…
RT @IPNA_PedNeph: One click to read about Eculizumab treatment in our free article of this month: https://t.co/2OS1njOMdY @Ped_Neph https:/…
RT @IPNA_PedNeph: One click to read about Eculizumab treatment in our free article of this month: https://t.co/2OS1njOMdY @Ped_Neph https:/…
One click to read about Eculizumab treatment in our free article of this month: https://t.co/2OS1njOMdY @Ped_Neph https://t.co/HIMHZZ8Wru
RT @ASPNeph: Eculizumab treatment in severe pediatric STEC-HUS: a multicenter retrospective study https://t.co/k6ukVUbHJC @Ped_Neph
RT @ASPNeph: Eculizumab treatment in severe pediatric STEC-HUS: a multicenter retrospective study https://t.co/k6ukVUbHJC @Ped_Neph
RT @Ped_Neph: 🆕 #Eculizumab treatment in severe pediatric STEC-HUS: multicenter retrospective study https://t.co/56Hx9KnKDR Shareable link…
🆕 #Eculizumab treatment in severe pediatric STEC-HUS: multicenter retrospective study https://t.co/56Hx9KnKDR Shareable link: https://t.co/WR4bDArU49 @CHUdeToulouse @APHP @hopital_necker @CHUBordeaux @HopRobertDebre @CHUnantes @ChuSteJustine @CHRU_Lille
RT @ASPNeph: Eculizumab treatment in severe pediatric STEC-HUS: a multicenter retrospective study https://t.co/k6ukVUbHJC @Ped_Neph
RT @ASPNeph: Eculizumab treatment in severe pediatric STEC-HUS: a multicenter retrospective study https://t.co/k6ukVUbHJC @Ped_Neph
RT @ASPNeph: Eculizumab treatment in severe pediatric STEC-HUS: a multicenter retrospective study https://t.co/k6ukVUbHJC @Ped_Neph
RT @ASPNeph: Eculizumab treatment in severe pediatric STEC-HUS: a multicenter retrospective study https://t.co/k6ukVUbHJC @Ped_Neph
Eculizumab treatment in severe pediatric STEC-HUS: a multicenter retrospective study https://t.co/k6ukVUbHJC @Ped_Neph